Aristotle University Of Thessaloniki (AUTH)
Συγκέντρωση μικροσωματιδίων στο πλάσμα γυναικών με σύνδρομο πολυκυστικών ωοθηκών κατά τη χορήγηση μετφορμίνης και αντισυλληπτικών δισκίων
Abstract
dc:descriptionPolycystic ovaries syndrome is the commonest endocrinopathy in women of reproductive age affecting their quality of life and health status, as it confers an increased cardiovascular risk. There are several therapeutic options for polycystic ovaries syndrome aiming at improving biochemical and hormonal parameters and preventing the complications. Routinely used therapeutic agents are combinations of contraceptives and metformin aiming at improvement of hyperandrogenemia and insulin resistance, respectively. Platelet microparticles (PMPs) are microvesicles shed from platelets following several stimuli and participate in inflammation, vascular homeostasis and thrombosis. They are involved in cardiovascular disease and were found increased in obese patients with polycystic ovaries syndrome. Agents that modulate hormonal aspects of PCOS could affect the level of PMPs. The aim of the present study was to evaluate the effects of oral contraceptive and metformin use for 6 and 12 months on platelet microparticles in normal-weight women with polycystic ovaries syndrome. Forty-five women with polycystic ovaries syndrome and 13 healthy women were recruited. All participants had normal body mass index (≤ 25 Kg/m2). Biochemical, hormonal and clinical parameters were recorded. Women with polycystic ovaries syndrome received treatment with combination of oral contraceptives, oral contraceptives+anti-androgens or metformin. Platelet microparticles were measured at baseline and after 6 and 12 months by means of flow cytometry. Statistical analysis was performed by means of the SPSS software (IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp., USA). At baseline, both groups had similar age (25±4 vs 26±2 years, p=0.064) and body mass index (23±3 vs 23±4 Kg/m2, p=0.830). Patients with polycystic ovaries syndrome had higher levels of platelet microparticles than controls (p=0.001) and increased after 6-month treatment with oral contraceptives (p=0.007). Subsequently, they decreased after 12-month treatment (p=0.046). Metformin had no effect on platelet microparticle levels. In detail, 8 patients received 3mg drospirenone+0,03mg ethinylestradiol, 20 patients received 0,035mg ethinylestradiol+2mg Cyproterone acetate, 5 patients received 0,035mg ethinylestradiol+2mg Cyproterone acetate+10mg Cyproterone acetate. Treatment for 6 and 12 months with combination of oral contraceptives improved FSH, LH, FAI και SHBG (p<0.019). Furthermore, testosterone and Δ4-A improved after 12-month use (p<0.048). Metformin use in women with polycystic ovaries syndrome changed the parameters of LH, FAI και SHBG, FSH, Δ4-A, testosterone and 17α-OHP (p<0.047). The use of any agent did not change the levels of platelet microparticles in patients with bilateral polycystic morphology of ovaries (p>0.1). Finally, significant correlations between platelet microparticles and testosterone, DHEAS, AFI and insulin sensitivity indexes (insulin, glucose/insulin ratio, AUC-OGTT, HOMA-IR, QUICKI) were detected. The stronger correlations were observed with testosterone, DHEAS and FAI. In conclusion, platelet microparticle levels are increased in polycystic ovaries syndrome and further increase with oral contraceptive use. This effect could possibly contribute to the increased risk of venous thromboembolism associated with oral contraceptive use. However, further studies are needed to elucidate the exact role of platelet microparticles in polycystic ovaries syndrome.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadakis, Efstathios
- Παπαδάκης, Ευστάθιος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47329